This clinical trial is focused on studying the effects of two treatments for women experiencing migraines related to their menstrual cycle or the perimenopausal phase. The diseases being studied are menstrually-related migraine and perimenopausal migraine. The trial will compare the use of a medication called ethinylestradiol/levonorgestrel, which is a combination of hormones often used in birth control, with vitamin E, a nutrient that acts as an antioxidant. The purpose of the study is to evaluate how these treatments affect the frequency of migraine days over a period of time.

Participants in the study will be asked to take either the hormone combination or vitamin E daily. The study will last for a total of 12 weeks, during which the number of migraine days will be monitored and recorded. This will help researchers understand if there is a significant change in the frequency of migraines when using these treatments. The study aims to provide insights into whether continuous daily use of these treatments can reduce the number of migraine days experienced by women with these specific types of migraines.

Throughout the study, participants will be monitored to assess the effectiveness of the treatments. The main focus will be on the change in the number of migraine days over a 28-day period, particularly during the last four weeks of the study. This information will help determine if either treatment is beneficial in managing migraines associated with menstrual cycles or the perimenopausal phase. The study will also look at other factors, such as the number of headache days and the number of migraine attacks, to provide a comprehensive understanding of the treatments’ effects.